Joanna Horobin's Net Worth
$445 Thousand
Who is Joanna Horobin?
Joanna Horobin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verastem, Inc., Kymera Therapeutics, Inc., IDERA PHARMACEUTICALS, INC., Vyant Bio, Inc., Liquidia Corp, and Liquidia Technologies Inc.
SEC CIK
Joanna Horobin's CIK is 0001560959
Past Insider Trading and Trends
2022 was Joanna Horobin's most active year for acquiring shares with 7 total transactions. Joanna Horobin's most active month to acquire stocks was the month of May. 2024 was Joanna Horobin's most active year for disposing of shares, totalling 3 transactions. Joanna Horobin's most active month to dispose stocks was the month of May. 2018 saw Joanna Horobin paying a total of $604,800.00 for 270,000 shares, this is the most they've acquired in one year. In 2024 Joanna Horobin cashed out on 17,000 shares for a total of $280,399.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Verastem, Inc. (VSTM) Snapshot price: $2.44
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
∞
| 750 |
$8.60 | $6,450.00 | 750 |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$17.54 | -$262,719.96 |
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDERA PHARMACEUTICALS, INC. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vyant Bio, Inc. (VYNT) Snapshot price: $0.177
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +48.25% | 7.53K |
—
|
—
| 23.12K |
Jan 17
| |||
Form 4
| +22.42% | 14.29K |
—
|
—
| 77.99K |
Oct 17
| |||
Form 4
| +14.55% | 8.09K |
—
|
—
| 63.71K |
Jul 18
| |||
Form 4
| +13.92% | 6.8K |
—
|
—
| 55.62K |
Apr 18
| |||
Form 4
| +813.74% | 43.48K |
—
|
—
| 48.82K |
Mar 30
| |||
Form 4
|
∞
| 5.34K |
$1.31 | $6,999.33 | 5.34K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Liquidia Corp (LQDA) Snapshot price: $9.2988
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 20.36K |
—
|
—
| 20.36K |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 24
| |||
| No matching records found | |||||||||